Prohibitin is overexpressed in Huh-7-HCV and Huh-7.5-HCV cells harboring in vitro transcribed full-length hepatitis C virus RNA
© Dang et al; licensee BioMed Central Ltd. 2011
Received: 5 March 2011
Accepted: 6 September 2011
Published: 6 September 2011
Currently, up-regulated proteins and apoptosis in hepatitis C is a hot topic in exploring the pathogenic mechanism of Heptitis C Virus(HCV). Some recent studies shows that prohibitin is overexpressed in cells expressing HCV core proteins, and up-regulated prohibitin is also found in human hepatoma cell line HCC-M, lung cancer, prostate cancer, and other cancers. Prohibitin is an important member of the membrane protein superfamily, and it plays a role of molecular chaperones in mitochondrial protein stability. Meanwhile, it has a permissive action on tumor growth or acts as an oncosuppressor. Based on our previously established the in vitro HCV cell-culture system (HCVcc), here we aimed to investigate the different expression profiles of prohibitin in Huh-7-HCV and Huh-7.5-HCV cells
The total cellular RNA of Huh-7, Huh-7.5, Huh-7-HCV and Huh-7.5-HCV cells were extracted, and then the first-strand cDNA was reversely transcribed. The expression of prohibitin at the mRNA level was assessed by real-time PCR with GAPDH as the control. Furthermore, the expression of prohibitin at the protein level was evaluated by western blot with GAPDH as an internal control.
Our results of real-time PCR showed that the mRNA expression level of prohibitin in Huh-7-HCV cells was 2.09 times higher than that in Huh-7 cells, while, the mRNA level of prohibitin in Huh-7.5-HCV cells was 2.25 times higher than that in Huh-7.5 cells. The results of western blot showed that the protein expression level of prohibitin in Huh-7-HCV cells was 2.38 times higher than that in Huh-7 cells, while the protein expression of prohibitin in Huh-7.5-HCV cells was 2.29 times higher than that in Huh-7.5 cells.
The expression of prohibitin was relatively high in Huh-7-HCV and Huh-7.5-HCV cells harboring in vitro transcribed full-length HCV RNA.
Hepatitis C virus (HCV) is a causative agent of human hepatitis C . HCV infection has become a global health problem with a prevalence of 170 million people, as estimated by the World Health Organization [2, 3]. Most (70-80%) HCV infections persist, and about 30% of individuals with persistent infection develop to chronic liver disease, including liver steatosis, cirrhosis and eventually hepatocellular carcinoma [4, 5]. However, the response rate is lower than 55% with the current pegylated interferon and ribavirin combination therapy in hepatitis C patients, and HCV also produces complications, such as depression and thyroid dysfunction . Therefore, almost half of patients are not satisfactorily resolved. Moreover, there are no commercial vaccines for hepatitis C prevention, which causes a very difficult problem.
The molecular mechanism of HCV replication, viral persistence and pathogenesis has not yet been fully elucidated. Up to now, the development of specific antiviral therapies and an effective vaccine has been hampered due to the lack of a convenient small animal model. The appearance of full length HCV RNA in vitro culture system makes it possible.
Prohibitin is a highly conserved protein, and it is widely distributed in bacteria, plants, fungi, protozoa, and mammals [7, 8]. It is a multifunctional protein that localizes at different intracellular sites. Prohibitin is an important member of the membrane protein superfamily, and it mainly exists in the mitochondrial inner membrane. This protein, plays a role of molecular chaperones in maintaining mitochondrial protein stability. It presents in the nucleus, involved in regulation of transcription . In addition, it can be found in the plasma membrane and cytoplasm . In recent years, over-expression of prohibitin has been detected in some tumor cells, including lung cancer, prostate cancer , cervical cancer , bladder cancer, gastric cancer , and breast cancer. Moreover, prohibitin may exert different functional roles, it has a permissive action on tumor growth or acts as an oncosuppressor .
In the present study, we compared the expression level of prohibitin in Huh-7 cells harboring full-length HCV RNA (Huh-7-HCV) and control Huh-7 cells. In addition, we evaluated its expression in Huh-7.5-HCV cells and control Huh-7.5 cells. We investigated the prohibitin expression at the mRNA level by real-time PCR and at the protein level by western blot. Our data provided a basis for understanding the function of prohibitin and the HCV pathogenesis which may lead to alternative ways for the treatment of Hepatitis C.
Materials and methods
Cell culture and transfection
Huh-7 and Huh-7.5 cells were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% heat-inactivated fetal bovine serum (FBS), 0.1 mM nonessential amino acids and 1 × penicillin-streptomycin-glutamine. Plasmid pFL-J6/JFH, containing a chimeric full-length HCV genome, was kindly provided by Professor Rice from Rockefeller University(USA), and it was transcribed to HCV RNA in vitro. Subsequently, HCV RNA was electroporately transfected into Huh-7 and Huh-7.5 cells. The in vitro HCV cell-culture system (HCVcc) was successfully established. Huh-7-HCV and Huh-7.5-HCV cells were maintained under the same condition as Huh-7 and Huh-7.5 cells. Huh-7, Huh-7.5, Huh-7-HCV and Huh-7.5-HCV cells were cultured in cell incubator at 37°C supplemented with 5% CO2. During the cell culture, the supernatant of cell culture was collected at 24, 48 and 72 hours post-electroporation in order to determine the HCV copy numbers. In addition, transmission electron microscopy was used to observe the morphological characteristics of virus particles in transfected Huh-7 and Huh-7.5 cells. At approximately 72 hours post-transfection, Huh-7-HCV and Huh-7.5-HCV cells were washed three times with 1 × phosphate-buffered saline (PBS) and then harvested, whereas Huh-7 and Huh-7.5 cells were collected as control.
Total RNA isolation, cDNA synthesis, RT-PCR and real-time PCR
Summary of RNA quantification
Primers used for RT-PCR and real-time PCR
Forward primer (5'-3')
Reverse primer (5'-3')
(RT-PCR, 835 bp)
(real-time PCR, 129 bp)
(real-time PCR, 138 bp)
In order to examine the mRNA expression of prohibitin, the expression of prohibitin and GAPDH genes was quantified by real-time PCR, and GAPDH served as an internal control. The length of the amplified PCR products ranged from 50 to 150 bp as recommended by Applied Biosystems. A total of 20 ng cDNA was used as template in the reaction. All real-time PCR assays were performed in triplicate with Bio-Rad iQ5 Multicolor Real-time PCR Detection System (America)according to the manufacture's protocol. Briefly, following a denaturation at 95°C for 5 sec, real-time PCR was carried out with 50 cycles at a melting temperature of 95°C for 30 sec, an annealing temperature of 60°C for 30 sec, and an extension temperature of 72°C for 10 sec. Data analysis was performed with the Sequence Detector System software. The relative quantification was calculated by the ΔΔCt method with GAPDH as the housekeeping gene and the non-transfected cells as the baseline, and the results were expressed as fold-change.
Protein extraction, SDS-PAGE and western blotting
To compare protein expression between the transfected and non-transfected cells, the total proteins were prepared by RIPA cell lysate. Proteins of interest were separated by SDS-polyacrylamide gel electrophoresis (PAGE) with a 10% polyacrylamide gel, and the protein concentration loaded on the SDS-PAGE was always at 1 mg/mL. Proteins were transferred to nitrocellulose membranes and then detected by western blotting under the recommended conditions. Rabbit anti-human IgG (Santa, America) was used as the primary antibody, goat anti-rabbit IgG conjugated with horseradish peroxidase (HRP) was used as the secondary antibody, and GAPDH was used as control. The antigen-antibody complex was detected by an enhanced chemiluminescence (ECL) kit following the manufacturer's protocol. The chemiluminescent signal of each band was analyzed by gel image analysis system. The expression levels of prohibitin and GAPDH in Huh-7-HCV and Huh-7.5-HCV cells were compared with those in Huh-7 and Huh-7.5 cells separately.
Detection of HCV at the RNA level in infected cellular supernatant and transmission electron microscopy observation
We detected HCV RNA in the supernatant of infected Huh-7 and Huh-7.5 cells. It reached a peak value at 48 hours post-transfection (6.4 × 106 copies), and the HCV RNA maintained at the same level in the supernatant until 72 hours post-transfection. The electron microscopy demonstrated that the cytoplasm of Huh-7-HCV and Huh-7.5-HCV cells contained a large number of spherical structures, which might be the nucleocapsid-like particles. Some characteristics of Flaviviridae virus infection appeared in the internal cellular structure, the rough endoplasmic reticulum increased, the endoplasmic network management dilated, vacuolar structures appeared in the cytoplasm, and a large number of HCV nucleocapsid-like particles of inclusion body presented in Huh-7-HCV and Huh-7.5-HCV cells. We did not find any form of virus-like particles in the control cells. Moreover, we did not observe the hyperplasia, vacuolar membrane structure and formation of inclusion bodies in the control cells.
Prohibitin expression at the mRNA level was up-regulated in Huh-7-HCV and Huh-7.5-HCV cells by real-time PCR
Prohibitin expression at the protein level was up-regulated in Huh-7-HCV and Huh-7.5-HCV cells by western blot analysis
Currently, much attention has been paid to the relationship between the up-regulated proteins after HCV infection and the pathology of liver injury. It is known that HCV creates the living environment for its reproduction, and it survives in the host cells by affecting the host cell apoptosis. Pathological changes in the liver tissue of hepatitis C patients include the lobular necrosis, the portal area like edge of eosinophilic necrosis, acidophilic corpuscle or Councilman bodies. Furthermore, apoptosis plays an important role in the pathogenesis of hepatitis C.
We hypothesized that the up-regulated proteins by HCV infection had a direct connection with the pathological liver injury. The new discovery of up-regulated proteins and elucidation of pathogenic mechanisms could provide some important insights into the treatment of hepatitis C. Tsutsumi et al. (2009) reported that the prohibitin expression is up-regulated not only in the HCV cells expressing core-protein, but also in the whole genome replication cells as well as the liver of core-gene transgenic mice . Their results suggest that high expression of prohibitin is significantly related to the cellular mitochondrial metabolism.
McClung et al. first cloned mammalian prohibitin gene in 1989. The prohibitin gene is located in chromosome 17q21, encoding a protein with a molecular weight of 32 kD . It is known that prohibitin protein functions as molecular chaperons and is involved in mitochondrial protein stability . In addition, prohibitin protein may contribute to the regulation of cell cycle , regulation of cell signal transduction, inhibition of cell proliferation , induction of apoptosis , anti-aging, maintenance of cell homeostasis and many cellular activities of life. However, its functional roles have not been well-defined and its specific mechanisms are unknown.
Jang et al. found that the expression of prohibitin is down-regulated in gastric cancer . Gamble et al. found that the expression of prohibitin is down-regulated more than 50% in androgen-mediated prostate cancer . In recent years, with the advance of experimental techniques, more and more studies show that the expression of prohibitin is up-regulated in tumor tissues and cells. For example, Seow et al. reported that the expression of prohibitin is up-regulated when detecting differentially expressed proteins in human hepatoma cell line HCC-M using two-dimensional electrophoresis .
In our study, we found that prohibitin was up-regulated in human hepatoma cells transfected with full-length HCV RNA compared with the control cells. Real-time PCR revealed that the prohibitin expression at the mRNA level in Huh-7-HCV cells was 2.09 times higher than that in Huh-7 control cells; while the prohibitin expression at the mRNA level in Huh-7.5-HCV cells was 2.25 times higher than that in Huh-7.5 control cells. Western blot analysis demonstrated that the prohibitin expression at the protein level in Huh-7-HCV cells was 2.38 times higher than that in Huh-7 control cells; while the prohibitin expression at the protein level in Huh-7.5-HCV cells was 2.29 times higher than that in Huh-7.5 control cells. Prohibitin was over-expressed both in Huh-7-HCV and Huh-7.5-HCV cells, which confirmed the universility of prohibitin up-regulating. Overexpression of prohibitin may have a close relationship with HCV RNA transcription, its down-regulation might decrease the replication of HCV RNA. In future, we will investigate the biological role of prohibitin and reveal the relationship between prohibitin and apoptosis. Those studies will provide a better understanding on the pathogenic mechanism of HCV and develop better approaches for the treatment of Hepatitis C.
We would like to thank Prof Charles M. Rice in HCV Research Center of Rockefeller University for providing us with the cells and plasmids. This project was supported by grants from National High-tech R&D Program (863 Program) of China (No. 2007AA02Z441) and Prevention and Treatment for Infectious Diseases of National Major Project of China (No. 2009ZX10004-715).
- Lee JH, Lee S, Park MY, Myung H: Characterization of thiobarbituric acid derivatives as inhibitors of hepatitis C virus NS5B polymerase. Virol J 2011, 14: 8-18.Google Scholar
- Bobeck DR, Schinazi RF, Coats SJ: Advances in nucleoside monophoaphate prodrugs as anti-HCV agents. Antivir Ther 2010,15(7):935-50. 10.3851/IMP1667View ArticlePubMedGoogle Scholar
- Javed T, Ashfaq UA, Riaz S, Rehman S, Riazuddin S: In-vitro antiviral activity of Solanum nigrum against Hepatitis C Virus. Virol J 2011, 19: 8-26.Google Scholar
- Bamaba V: Hepatitis C virus infection: a "liasion a trois" amongst the virus, the host, and chronic low-level inflammation for human survival. J Hepatol 2010,53(4):752-61. 10.1016/j.jhep.2010.06.003View ArticleGoogle Scholar
- Lemon SM, Mckeating JA, Pietschmann T, Frick DN, Glenn JS, Tellinghuisen TL, Symons J, Furman PA: Development of novel therapies for hepatitis C. Antiviral Res 2010,86(1):79-92. 10.1016/j.antiviral.2010.02.003View ArticlePubMedGoogle Scholar
- Foster GR: Pegylated interferons for the treatment of chronic hepatitis C: pharmacological and clinical differences between peginterferon-alpha-2a and peginterferon-alpha-2b. Drugs 2010,70(2):147-65. 10.2165/11531990-000000000-00000View ArticlePubMedGoogle Scholar
- Sanchez-Quiles V, Santamaria E, Segura V, Sesma L, Prieto J, Corrales FJ: Prohibitin deficiency blocks proliferation and induces apoptosis in human hepatoma cells: Molecular mechanisms and functional implications. Proteomics 2010,10(8):1609-20. 10.1002/pmic.200900757View ArticlePubMedGoogle Scholar
- Peng X, Mthta R, Wang S, Chellappan S, Mthta RG: Prohibitin is a novel target gene of vitamin D involved in its antiproliferative action in breast cancer cells. Cancer Res 2006,66(14):7361-9. 10.1158/0008-5472.CAN-06-1004View ArticlePubMedGoogle Scholar
- Rizwani W, Alexandrow M, Chellappan S: Prohibitin physically interacts with MCM proteins and inhibits mammalian DNA replication. Cell Cycle 2009, 8: 1621-1629. 10.4161/cc.8.10.8578PubMed CentralView ArticlePubMedGoogle Scholar
- Woodlock TJ, Bethlendy G, Segel GB: Prohibitin expression is increased in phorbol ester-treated chronic leukemic B-lymphocytes. Blood Cells Mol Dis 2001, 27: 27-34. 10.1006/bcmd.2000.0348View ArticlePubMedGoogle Scholar
- Mengwasser J, Piau A, Schlag P, Sleeman JP: Differential immunization identifies PHB1/PHB2 as blood-borne tumor antigens. Oncogene 2004, 23: 7430-7435. 10.1038/sj.onc.1207987View ArticlePubMedGoogle Scholar
- Tsai HW, Chow NH, Lin CP, Chan SH, Chou CY, Ho CL: The significance of prohibitin and c-Met/hepatocye growth factor receptor in the progression of cervical adenocarcinoma. Hum Pathol 2006, 37: 198-204. 10.1016/j.humpath.2005.10.012View ArticlePubMedGoogle Scholar
- Kang X, Zhang L, Sun J, Ni Z, Ma Y, Chen X, Sheng X, Chen T: Prohibitin: a potential biomarker for tissue-based detection of gastric cancer. J Gastroenterol 2008, 43: 618-625. 10.1007/s00535-008-2208-3View ArticlePubMedGoogle Scholar
- Nan Y, Yang S, Tian Y, Zhang W, Zhou B, Bu L, Huo S: Analysis of the expression protein profiles of lung squamous carcinoma cell using shot-gun proteomics strategy. Med Oncol 2009, 26: 215-221. 10.1007/s12032-008-9109-4View ArticlePubMedGoogle Scholar
- Tsutsumi T, Matsuda M, Aizaki H, Moriya K: Proteomics analysis of mitochondrial proteins reveals overexpression of a mitochondrial protein chaperon, prohibitin, in cells expressing hepatitis C virus core protein. Hepatology 2009,50(2):378-86. 10.1002/hep.22998View ArticlePubMedGoogle Scholar
- Sato T, Saito H, Swensen J, Olifant A, Wood C, Danner D, Sakamoto T, Takita K, Kasumi F, Miki Y: The human prohibitin gene located on chromosome 17q21 is mutated in sporadic breaset cancer. Cancer Res 1992, 52: 1643-1646.PubMedGoogle Scholar
- Mishra S, Murphy LC, Murphy LJ: The prohibitins: emerging roles in diverse functions. J Cell Mol Med 2006, 10: 353-363. 10.1111/j.1582-4934.2006.tb00404.xPubMed CentralView ArticlePubMedGoogle Scholar
- Rastogi S, Joshi B, Dasgupta P, Morris M, Wright K, Chellappan S: Prohibitin facilitates cellular senescence by recruiting specific corepressors to inhibit E2F target genes. Mol Cell Biol 2006, 26: 4161-4171. 10.1128/MCB.02142-05PubMed CentralView ArticlePubMedGoogle Scholar
- Fusaro G, Dasgupta P, Rastogi S, Joshi B, Chellappan S: Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling. J Biol Chem 2003, 278: 47853-47861. 10.1074/jbc.M305171200View ArticlePubMedGoogle Scholar
- Joshi B, Ko D, Ordonez-Ercan D, Chellappan SP: A putative coiled-coil domain of prohibitin is sufficient to repress E2F1-mediated transcription and induce apoptosis. Biochem Biophys Res Commun 2003, 312: 459-466. 10.1016/j.bbrc.2003.10.148View ArticlePubMedGoogle Scholar
- Jupe ER, Liu XT, Kiehlbauch JL, McClung JK, Dell'Orco RT: The 3' untranslated region of prohibitin and cellular immortalization. Exp Cell Res 1996, 224: 128-135. 10.1006/excr.1996.0120View ArticlePubMedGoogle Scholar
- Gamble SC, Odontiadis M, Waxm an J: Androgens target prohibitn to regulate proliferation of prostate cancer cells. Oncogene 2004, 23: 2996-3004. 10.1038/sj.onc.1207444View ArticlePubMedGoogle Scholar
- Seow TK, Ong SE, Liang RC, Ren EC, Chan L, Ou K, Chung MC: Two-dimensional electrophoresis map of the human hepatocellular carcinoma cell line, HCC-M, and identification of the separated proteins by mass spectrometry. Electrophoresis 2000, 21: 1787-1813. 10.1002/(SICI)1522-2683(20000501)21:9<1787::AID-ELPS1787>3.0.CO;2-AView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.